Award
Delivery Order #SPE2DR26FAVPP
AmerisourceBergen Drug Corp Awarded Delivery Order for Vyvanse Medication
Buyer
Defense Logistics Agency
Award Amount
$2,590.14
Ceiling
$2,590.14
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FAVPP
NAICS
325411
This contract is a delivery order awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical services company, for the procurement of Vyvanse 50mg medication. The delivery order is a task under the broader indefinite delivery vehicle (IDV) held by AmerisourceBergen, which supports pharmaceutical supply chain operations primarily in European regions. The awarded order involves the supply of a specific dosage and quantity of Vyvanse, a medication commonly used for attention deficit hyperactivity disorder (ADHD), highlighting its importance in healthcare provisioning. The contract underpins critical pharmaceutical distribution efforts, ensuring timely and reliable medication availability for government or institutional needs. This particular delivery order was competitively awarded as an extension of the existing IDV, supporting an ongoing long-term procurement strategy. The timeline for this delivery order is short-term, spanning a few days, reflecting a focused and immediate fulfillment requirement. The contract contributes to the wider goal of sustaining essential medication supply chains and enhancing healthcare service outcomes.
Description
4570896186!VYVANSE 50MG 100S